Liposome-based delivery system for vaccine candidates: constructing an effective formulation.
about
Recent progress in adjuvant discovery for peptide-based subunit vaccinesDevelopment of oligomannose-coated liposome-based nasal vaccine against human parainfluenza virus type 3.Liposome-like Nanostructures for Drug Delivery.Novel platform technology for modular mucosal vaccine that protects against streptococcus.Mucosal Vaccine Development Based on Liposome Technology.Toll-like receptor agonists: a patent review (2011 - 2013).Intranasal formulations: promising strategy to deliver vaccines.Oral delivery of nanoparticle-based vaccines.Recent advances in peptide-based subunit nanovaccines.Vaccine technologies: From whole organisms to rationally designed protein assemblies.Peptide-based synthetic vaccines.Inflammatory monocyte/macrophage modulation by liposome-entrapped spironolactone ameliorates acute lung injury in miceDevelopment of Peptide Vaccines in Dengue.Group A Streptococcal vaccine candidate: contribution of epitope to size, antigen presenting cell interaction and immunogenicity.Development of plumbagin-loaded phospholipid-Tween® 80 mixed micelles: formulation, optimization, effect on breast cancer cells and human blood/serum compatibility testing.Functionalized liposome purification via Liposome Extruder Purification (LEP).Supramolecularly engineered phospholipids constructed by nucleobase molecular recognition: upgraded generation of phospholipids for drug delivery.Targeting of AUF1 to vascular endothelial cells as a novel anti-aging therapy.The Multirole of Liposomes in Therapy and Prevention of Infectious Diseases.Nanoparticle Vaccines Against Infectious Diseases
P2860
Q34033780-844936D4-30D8-4D62-B40F-975960790D23Q37342874-E78C88E0-C706-49DD-B8F9-75CBAE021E6FQ37424654-C352DA86-1E6E-4883-AD8A-AAC0A470E0C0Q37504796-3B6F556A-A19C-4149-B8EE-21AFD9C225D1Q37581129-615BBBC2-35FE-4814-87D8-842037BD7056Q38181176-40688F80-2D18-4F7E-9E45-E2EF54050695Q38223050-B05A275E-0DFE-4771-86F0-B35A7FB6CC07Q38243119-678CAB19-D26C-43AB-9F6B-7AAEFBEF7308Q38296076-BB934736-8B9B-485F-B411-79B89DAB56DCQ38806558-1D588D16-7CED-459C-8329-4B911CDB6B92Q38914295-4EF2DC91-C953-4617-AF48-B89CD9EF288AQ39739187-FA2CBB39-0B46-42CA-959E-B8D39203A85BQ40038715-BC40D803-98FD-46D2-ADA8-6C74A00F339BQ41588446-6976E3E9-205E-49A7-9DF8-19807F615359Q44794686-8D90397D-DBF5-45FF-ABE9-A75A9205C1D7Q46304429-3D68A1A1-3954-43AE-B25D-6A3248828EE8Q47141205-DC55AFD7-DE23-4B89-943A-33497AC2BC0FQ47382076-2F84A3AF-5621-4AE1-A351-12F312A19BB7Q50124824-65F17520-6165-4524-A14C-3AC8FF9E6C61Q58583890-EC32E79F-A3DE-445A-A742-EF44DBAEC4C5
P2860
Liposome-based delivery system for vaccine candidates: constructing an effective formulation.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Liposome-based delivery system ...... ting an effective formulation.
@en
type
label
Liposome-based delivery system ...... ting an effective formulation.
@en
prefLabel
Liposome-based delivery system ...... ting an effective formulation.
@en
P2860
P356
P1433
P1476
Liposome-based delivery system ...... cting an effective formulation
@en
P2093
Ashwini Kumar Giddam
Mehfuz Zaman
P2860
P304
P356
10.2217/NNM.12.157
P577
2012-12-01T00:00:00Z